Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42001719EBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS10006549HBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS10008067HBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS10008068HBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30003991HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30079115HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30087748HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30081211HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30081546HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30082146HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TCGA Plot Options
Drug Information
GeneEGFR
DrugBank IDDB05524
Drug NamePelitinib
Target IDBE0000767
UniProt IDP00533
Regulation Type
PubMed IDs16364494
CitationsYoshimura N, Kudoh S, Kimura T, Mitsuoka S, Matsuura K, Hirata K, Matsui K, Negoro S, Nakagawa K, Fukuoka M: EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib. Lung Cancer. 2006 Mar;51(3):363-8. Epub 2005 Dec 20.
GroupsInvestigational
Direct Classification
SMILESCCOC1=CC2=C(C=C1NC(=O)C=CCN(C)C)C(NC1=CC(Cl)=C(F)C=C1)=C(C=N2)C#N
Pathways
PharmGKB
ChEMBLCHEMBL607707